Expression of p53 protein and Ki-67 reactivity in ovarian neoplasms: Correlation with histopathology

American Journal of Clinical Pathology

Volumn 105, Issue 3, 1996, Pages 334-340

  Harlozinska A ^a   Bar, Julia K ^a   Sedlaczek, P ^a   Gerber, J ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Histological subtypes; Immunohistochemistry; Ki 67 antigen; Ovarian neoplasms; p53 protein; Stage of disease

Indexed keywords

MONOCLONAL ANTIBODY KI 67; PROTEIN P53; TUMOR ANTIGEN;

ANTIGEN DETECTION; ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029963918     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/105.3.334     Document Type: Article

References (23)

1. Eccles DM, Brett L, Lessells A, at al. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Br J Cancer 1992;65:40-44.
2. Gotlieb WH, Berek JS. Advances in the biology of gynecologic cancer. Curr Opin Oncol 1994;6:513-518.
3. Mazars R, Pujol P, Maudelonde T, Jeanteur P, Theillet C. p53 mutations in ovarian cancer: A late event? Oncogene 1991;6: 1685-1690.
4. Harłozińska A, Bar JK. Relationship between p53 and c-erbB-2 Overexpression in tissue sections and cyst fluid cells of patients with ovarian cancer. Tumor Biol 1994;15:223-229.
5. Berchuck A, Kohler MF, Hopkins MP, et al. Overexpression of p53 is not a feature of benign and early-stage borderline epithelial ovarian tumors. Gynecol Oncol 1994;52:232-236.
6. Marks JR, Davidoff AM, Kerns BJ, et al. Overexpression and mutation of p53 in epithelial ovarian cancer. Cancer Res 1991;51: 2979-2984.
7. Klemi PJ, Takahashi S, Joensuu H, et al. Immunohistochemical detection of p53 protein in borderline and malignant serous ovarian tumors. Int J Gynecol Pathol 1994;13:228-233.
8. Hartmann LC, Podratz KC., Keeney GL, et al. Prognostic significance of p53 immunostaining in epithelial ovarian cancer. J Clin Oncol 1994;12:64-69.
9. Renninson J, Baker BW, McGown AT, et al. Immunohistochemical detection of mutant p53 protein in epithelial ovarian cancer using polyclonal antibody CMI: correlation with histopathology and clinical features. Br J Cancer 1994;69:609-612.
10. Kupryjańczyk J, Thor AD, Beauchamp R, et al. p53 gene mutations and protein accumulation in human ovarian cancer. Proc Nat Acad Sci USA 1993;90:4961-4965.
11. Tsao S-W, Mok C-H, Knapp RC, el al. Molecular genetic evidence of a unifocal origin for human serous ovarian carcinomas. Gynecol Oncol 1993;48:5-10.
12. Kerns B-J, Jordan PA, Faerman LL, et al. Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis. Am J Clin Pathol 1994;101:192-197.
13. Kiyokawa T. Alteration of p53 in ovarian cancer: Its occurrence and maintenance in tumor progression. Int J Gvnecol Pathol 1994;13:311-318.
14. Zusman I. The clinical relevance of p53 oncoprotein determination in cancer diagnosis and prognosis (Review). Oncol Rep 1995;2:143-150.
15. Wong WSF, Tattersall MHN. Immunohistochemical determination of tumor growth fraction in human ovarian carcinoma. Br J Obstet Gynaecol 1989;96:720-724.
16. Henzen-Logmans SC, Fieret EJH, Berns EMJJ, Van der Burg MEL, Klijn JGM. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: Correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D. Int J Cancer 1994;57:468-472.
17. Huettner PC, Weinberg DS, Lage JM. Assessment of proliferative activity in ovarian neoplasms by flow and static cytometry. Am J Pathol 1992;141:699-706.
18. Isola J, Kallioniemi O-P, Korte J-M, et al. Steroid receptors and Ki-67 reactivity in ovarian cancer and in normal ovary: Correlation with DNA flow cytometry, biochemical receptor assay, and patient survival. J Pathol 1990;162:295-301.
19. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983;31:13-20.
20. Harłozińska A, Bar JK, Cislo M, Richter R, Rabczyǹski J. Density distribution and immunological reactivity of tumor cells from peritoneal effusions of patients with ovarian neoplasms. Anal Cell Pathol 1992;4:1-12.
21. Mok C-H, Tsao S-W, Knapp RC, Fishbaugh PM, Lau CC. Unifocal origin of advanced human epithelial ovarian cancers. Cancer Res 1992;52:5119-5122.
22. Milner BJ, Allan LA, Eccles DM, et al. p53 mutation is a common genetic event in ovarian carcinoma. Cancer Res 1993;53:2128-2132.
23. Kihana T, Tsuda H, Teshima S, et al. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy. Jpn J Cancer Res 1992;83:978-984.